Tropical Medicine and Infectious Disease (Jan 2021)

Monitoring of the Sensitivity In Vivo of <i>Plasmodium falciparum</i> to Artemether-Lumefantrine in Mali

  • Modibo Diarra,
  • Drissa Coulibaly,
  • Amadou Tapily,
  • Boureima Guindo,
  • Koualy Sanogo,
  • Diakalia Koné,
  • Youssouf Koné,
  • Karim Koné,
  • Aboudramane Bathily,
  • Oumar Yattara,
  • Mahamadou A. Thera,
  • Alassane Dicko,
  • Abdoulaye A. Djimdé,
  • Issaka Sagara

DOI
https://doi.org/10.3390/tropicalmed6010013
Journal volume & issue
Vol. 6, no. 1
p. 13

Abstract

Read online

In Mali, since 2007, artemether-lumefantrine has been the first choice against uncomplicated malaria. Despite its effectiveness, a rapid selection of markers of resistance to partner drugs has been documented. This work evaluated the treatment according to the World Health Organization’s standard 28-day treatment method. The primary endpoint was the clinical and parasitological response corrected by a polymerase chain reaction. It was more than 99.9 percent, the proportion of patients with anemia significantly decrease compared to baseline (p Plasmodium falciparum remains sensitive to artemether-lumefantrine in Mali.

Keywords